ACMIT is pleased to announce its participation in the LISAvienna Regulatory Affairs Conference 2026, taking place on 15 October 2026 at the Apothekertrakt, Schönbrunn Palace, Vienna, Austria.
Celebrating its 10th edition, the conference is dedicated to Medical Devices and In-vitro Diagnostics and brings together experts from notified bodies, authorities, industry, and research organizations.
Participants can expect a full day of expert presentations, interactive discussions, and practical insights covering the latest developments in MDR, IVDR, and other key regulatory topics. The programme includes a series of focused conference sessions designed to address current challenges in market authorization and regulatory compliance.
Held in English and supported by LISA – Life Science Austria, the event also offers dedicated partnering opportunities through the b2match platform, fostering exchange and collaboration within the international life sciences community.
ACMIT values the opportunity to stay informed about evolving regulatory requirements and engage with experts shaping the future regulatory landscape of medical technology.
For more information, please visit:
